The DOI matches its Crossref record; 23 of the 25 references it cites were found in a registry or an index.
COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study
Open accessAbstract
BACKGROUND: In early 2020, during the COVID-19 pandemic, New Zealand implemented graduated, risk-informed national COVID-19 suppression measures aimed at disease elimination. We investigated their impacts on the epidemiology of the first wave of COVID-19 in the country and response performance measures. METHODS: We did a descriptive epidemiological study of all laboratory-confirmed and probable cases of COVID-19 and all patients tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in New Zealand from Feb 2 to May 13, 2020, after which time community transmission ceased. We extracted data from the national notifiable diseases database and the national SARS-CoV-2 test results repository. Demographic features and disease outcomes, transmission patterns (source of infection, outbreaks, household transmission), time-to-event intervals, and testing coverage were described over five phases of the response, capturing different levels of non-pharmaceutical interventions. Risk factors for severe outcomes (hospitalisation or death) were examined with multivariable logistic regression and time-to-event intervals were analysed by fitting parametric distributions using maximum likelihood estimation. FINDINGS: 1503 cases were detected over the study period, including 95 (6·3%) hospital admissions and 22 (1·5%) COVID-19 deaths. The estimated case infection rate per million people per day peaked at 8·5 (95% CI 7·6-9·4) during the 10-day period of rapid response escalation, declining to 3·2 (2·8-3·7) in the start of lockdown and progressively thereafter. 1034 (69%) cases were imported or import related, tending to be younger adults, of European ethnicity, and of higher socioeconomic status. 702 (47%) cases were linked to 34 outbreaks. Severe outcomes were associated with locally acquired infection (crude odds ratio [OR] 2·32 [95% CI 1·40-3·82] compared with imported), older age (adjusted OR ranging from 2·72 [1·40-5·30] for 50-64 year olds to 8·25 [2·59-26·31] for people aged ≥80 years compared with 20-34 year olds), aged residential care residency (adjusted OR 3·86 [1·59-9·35]), and Pacific peoples (adjusted OR 2·76 [1·14-6·68]) and Asian (2·15 [1·10-4·20]) ethnicities relative to European or other. Times from illness onset to notification and isolation progressively decreased and testing increased over the study period, with few disparities and increasing coverage of females, Māori, Pacific peoples, and lower socioeconomic groups. INTERPRETATION: New Zealand's response resulted in low relative burden of disease, low levels of population disease disparities, and the initial achievement of COVID-19 elimination. FUNDING: Ministry of Business Innovation and Employment Strategic Scientific Investment Fund, and Ministry of Health, New Zealand.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other countries, such as Australia and New Zealand, have shown how early and effective lockdowns, combined with geographical isolation and travel restrictions, have kept transmission low throughout the study period.18, 55, 56”
From Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis (2022) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker)
Hale, T., Angrist, N., Goldszmidt, R., Kira, B., Petherick, A., Phillips, T., Webster, S., Cameron-Blake, E., Hallas, L., Majumdar, S., et al. (2021) · Nature Human Behaviour · doi:10.1038/s41562-021-01079-8 · Cited by 4,578
How will country-based mitigation measures influence the course of the COVID-19 epidemic?
Anderson, R. M., Heesterbeek, H., Klinkenberg, D., & Hollingsworth, T. D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30567-5 · Cited by 3,648
Ferguson, N. M., Laydon, D. J., Nedjati-Gilani, G. L., Imai, N., Ainslie, K. E. C., Baguelin, M., Bhatia, S., Boonyasiri, A., Cucunubá, Z. M., Cuomo-Dannenburg, G., et al. (2020) · Spiral (Imperial College London) · doi:10.25561/77482 · Cited by 3,619
A leisurely look at the bootstrap, the jackknife, and cross-validation
Efron, B., & Gong, G. (1983) · The American Statistician · doi:10.1080/00031305.1983.10483087 · Cited by 3,229
Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)
Gomes, C. A. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2,134
Pan, A., Liu, L., Wang, C., Guo, H., Hao, X., Wang, Q., Huang, J., He, N., Yu, H., Lin, X., et al. (2020) · JAMA · doi:10.1001/jama.2020.6130 · Cited by 1,931
The effect of large-scale anti-contagion policies on the COVID-19 pandemic
Hsiang, S., Allen, D., Annan-Phan, S., Bell, K., Bolliger, I. W., Chong, T., Druckenmiller, H., Huang, L. Y., Hultgren, A., Krasovich, E., et al. (2020) · Nature · doi:10.1038/s41586-020-2404-8 · Cited by 1,528
Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing
Wang, C. J., Ng, C. Y., & Brook, R. H. (2020) · JAMA · doi:10.1001/jama.2020.3151 · Cited by 1,391
Oxford COVID-19 Government Response Tracker
Hale, T. N., & Webster, S. (2020) · Cited by 1,184
Cited by
Sorted by citations
Non-pharmaceutical interventions during the COVID-19 pandemic: A review
Perra, N. (2021) · Physics Reports · doi:10.1016/j.physrep.2021.02.001 · Cited by 540
Huang, Q. S., Wood, T., Jelley, L., Jennings, T., Jefferies, S., Daniells, K., Nesdale, A., Dowell, T., Turner, N. M., Campbell‐Stokes, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21157-9 · Cited by 456
Self-citationBarber, R. M., Sorensen, R. J. D., Pigott, D. M., Bisignano, C., Carter, A., Amlag, J. O., Collins, J. K., Abbafati, C., Adolph, C., Allorant, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00484-6 · Cited by 298
Work and worker health in the post-pandemic world: a public health perspective
Peters, S. E., Dennerlein, J. T., Wagner, G. R., & Sorensen, G. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00259-0 · Cited by 187
Gurney, J., Millar, E., Dunn, A., Pirie, R., Mako, M., Manderson, J., Hardie, C. M., Jackson, C., North, R. T., Ruka, M., et al. (2021) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2021.100127 · Cited by 164
Metadata
- Authors
- Jefferies, S., French, N., Gilkison, C., Graham, G., Hope, V., Marshall, J., McElnay, C., McNeill, A., Muellner, P., Paine, S., Prasad, N., Scott, J., Sherwood, J., Yang, L., & Priest, P.
- Affiliations
- New Zealand Institute for Public Health and Forensic Science (NZ)
- Massey University (NZ)
- Ministry of Health (NZ)
- University of Otago (NZ)
- Corresponding author
- Jefferies, Sarah
- ORCID
- Venue
- The Lancet Public Health
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 5
- Issue
- 11
- Pages
- e612-e623
- ISSN
- 2468-2667 (ISSN-L)
- PMC
- PMC7553903
- OpenAlex
- W3093036788
- Cited by
- 349
- References
- 25
- Citations by year
- 2026: 7 · 2025: 23 · 2024: 31 · 2023: 45 · 2022: 62 · 2021: 174 · 2020: 7
- FWCI
- 11.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- The Lancet Public Health (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Health, New Zealand
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Social Sciences › Sociology and Political Science › COVID-19 Prevention and Impact
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- COVID-19 pandemic, SARS-CoV-2, New Zealand, non-pharmaceutical interventions, lockdown, imported infections, household transmission, community outbreak, severe outcomes, hospitalization, mortality, risk factors, residential care, Pacific Islanders, socioeconomic status, test coverage, infection rate, response performance, first wave, survival analysis
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, COVID-19 Testing, Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Humans, Infant, Male, Middle Aged, New Zealand, Pneumonia, Viral, Risk Factors, Epidemiologic Studies, Coronavirus Infections, Clinical Laboratory Techniques, Young Adult, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
